NCT03947034View on ClinicalTrials.gov

Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)

CompletedOBSERVATIONAL
Enrollment

2,700

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

May 30, 2020

Study Completion Date

April 4, 2023

Conditions
HyperammonemiaMetabolic DiseaseAdverse Drug EventDrug Toxicity
Interventions
DRUG

Drugs inducing hyperammonemia

Drugs susceptible to induce metabolic toxicities such as hyperammonemia

Trial Locations (1)

75013

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03947034 - Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) | Biotech Hunter | Biotech Hunter